Arkolith/Insider Trading/NKGN/Form 4

Park Sangwoo

Director, 10% OwnerNKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Dec 15, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2023Gift(G)2.5M—$010.1M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-058901) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML